ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
John R. Benfield
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Benfield, J. R.
Right arrow Articles by Teplitz, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Benfield, J. R.
Right arrow Articles by Teplitz, R. L.

Ann Thorac Surg 1984;38:627-632
© 1984 The Society of Thoracic Surgeons


Articles

A Family of Epidermoid Lung Cancer Models

John R. Benfield, M.D.*, William G. Hammond, M.D., Edwin C. Shors, Ph.D., Rao Paladugu, M.D., Hyun Y. Pak, M.D., Raymond L. Teplitz, M.D.

Divisions of Surgery, Anatomic Pathology, and Cytogenetics and Cytology, City of Hope National Medical Center, Duarte, CA

* Address reprint requests to Dr. Benfield, City of Hope National Medical Center, Duarte, CA 91010

A method of sustained release implantation has been developed whereby Silastic cylinders, impregnated with benzo[a]pyrene (BP) or methylcholanthrene (MCA) each at 2% (low dose) and 10% (high dose) concentrations, were inserted into the bronchus intermedius of hamsters. High-dose BP and MCA, and low-dose MCA had first-order exponential release rates: the half-time of release was 40 days for high-dose BP, 30 days for high-dose MCA, and 165 days for low-dose MCA. Release rate of low-dose BP was a second-order function: half-time of release was 40 days. Atypical squamous metaplasia was noted by 4 weeks in more than 65% of hamsters after insertion of each high-dose carcinogen but in less than 30% with the low-dose carcinogens. Carcinoma in situ was noted approximately 8 weeks after high-dose BP and 19 weeks after low-dose BP. At about 15 to 17 weeks after a high-dose carcinogen, 64% of animals had invasive epidermoid cancer, whereas after a low-dose carcinogen, only 21% did. After 25 weeks of exposure to a high-dose carcinogen, more than 85% of hamsters had invasive epidermoid cancer; up to 52 weeks were required for invasive epidermoid cancer to develop in 30% after a low-dose carcinogen. Measured by image analysis, nuclear deoxyribonucleic acid content of cells with severe atypical squamous metaplasia was greater than tetraploid (mean ± standard deviation [SD], 3.77 ± 1.4), whereas cells with invasive epidermoid cancer were suprahexaploid (mean ± SD, 6.48 ± 3.6). These differences are significant (p < 0.05). We conclude that the developmental continuum of epidermoid lung cancer can now be reproduced in controlled, predictable fashion in hamsters.




This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
R. W. Sawyer, W. G. Hemmond, R. L. Teplitz, and J. R. Benfield
Regression of bronchial epithelial cancer in hamsters
Ann. Thorac. Surg., July 1, 1993; 56(1): 74 - 79.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
W. G. Hammond, R. L. Teplitz, and J. R. Benfield
Lung cancer model for study of the metastatic process
Ann. Thorac. Surg., October 1, 1991; 52(4): 732 - 737.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1984 by The Society of Thoracic Surgeons.